We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hits Theken Spine With Warning Letter for QS Deviations
FDA Hits Theken Spine With Warning Letter for QS Deviations
June 2, 2006
The FDA issued a May 15 warning letter to Akron, Ohio-based Theken Spine for Quality System (QS) regulation deficiencies.